- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Autonomix Medical, Inc.: Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar | 1 | GlobeNewswire (USA) | ||
| 16.04. | Autonomix gets patent covering proprietary catheter-based technology | 1 | Seeking Alpha | ||
| 16.04. | Autonomix Medical, Inc.: Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain | 1 | GlobeNewswire (USA) | ||
| 16.04. | Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology | 146 | JCN Newswire | Company is targeting pancreatic cancer pain with advanced nerve detection and treatment technologyNEW YORK, Apr 16, 2024 - (ACN Newswire) - A new article on Autonomix Medical Inc. (NASDAQ: AMIX), featuring... ► Artikel lesen | |
| 09.04. | Autonomix announces positive preclinical study for its catheter-based sensing technology | 1 | Seeking Alpha | ||
| 08.04. | Autonomix Medical, Inc.: Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker | 1 | GlobeNewswire (USA) | ||
| 27.03. | Autonomix Medical, Inc.: Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference | 2 | GlobeNewswire (USA) | ||
| 20.03. | Autonomix Medical, Inc.: Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024 | 1 | GlobeNewswire (USA) | ||
| 19.03. | Autonomix Medical, Inc.: Autonomix Appoints Jennifer Cook as Chief Business Officer | 2 | GlobeNewswire (USA) | ||
| 14.03. | Autonomix completes first procedures in pancreatic cancer ablation trial | 1 | MassDevice | ||
| 14.03. | Autonomix Medical, Inc.: Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market | 66 | GlobeNewswire (Europe) | First trial to ever evaluate radiofrequency (RF) ablation in a transvascular approach to reduce the pain associated with pancreatic cancer THE WOODLANDS, TX, March 14, 2024 (GLOBE NEWSWIRE) -- Autonomix... ► Artikel lesen | |
| 04.03. | Autonomix Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.02. | Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity | 1 | GlobeNewswire (USA) | ||
| 16.02. | Autonomix advances pancreatic cancer pain treatment study | 1 | Investing.com | ||
| 16.02. | Autonomix Medical, Inc.: Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market | 2 | GlobeNewswire (USA) | ||
| 14.02. | Autonomix Medical, Inc. reports 9M results | 2 | Seeking Alpha | ||
| 14.02. | Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones | 170 | GlobeNewswire (Europe) | Company developing potential breakthrough technology for the nervous system Initially targeting multi-billion-dollar pancreatic cancer market On track to commence first study ever to evaluate radiofrequency... ► Artikel lesen | |
| 13.02. | Autonomix Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 09.02. | Autonomix Medical, Inc. to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference | 277 | ACCESSWIRE | Webcast presentation on Wednesday, February 14th at 10:30 AM ESTTHE WOODLANDS, TX / ACCESSWIRE / February 9, 2024 / Autonomix Medical, Inc. (NASDAQ:AMIX) ("Autonomix" or the "Company"), a medical device... ► Artikel lesen | |
| 06.02. | Autonomix Medical to start pancreatic cancer pain study | - | Investing.com |
Seite:
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CHROMADEX | 3,260 | +1,24 % | ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results | LOS ANGELES--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ:CDXC) today announced fourth quarter and fiscal year 2023 financial results.
Fourth Quarter 2023 and Recent Highlights
Total net sales... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 52,94 | +1,22 % | DZ BANK stuft Siemens Healthineers auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Siemens Healthineers vor Zahlen von 52 auf 53 Euro angehoben und die Einstufung auf "Halten" belassen. Analyst Sven Kürten erwartet... ► Artikel lesen | |
| FRESENIUS | 27,210 | +0,11 % | Fresenius und FMC: Aktien im Aufwind - das beflügelt | Die Aktien von Fresenius und ihrer ehemaligen Tochtergesellschaft Fresenius Medical Care (FMC) zeigen am Montag eine robuste Performance. Die Fresenius-Aktie erreichte zwischenzeitlich den höchsten... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,420 | -0,98 % | FMC: Erfolge werden deutlicher | Fresenius Medical Care (FMC) erwirtschaftet derzeit rund 70 Prozent des Umsatzes in den USA. Dabei ist das dortige Geschäft überdurchschnittlich profitabel für FMC. Sollte es in dem Land zu Steuersenkungen... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 100,30 | +1,31 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 51,83 | -0,86 % | PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GERRESHEIMER | 100,50 | +1,31 % | Gerresheimer wieder dreistellig - Jefferies hebt den Daumen | Zum Wochenauftakt geht es für die Gerresheimer-Aktie um zwei Prozent nach oben. Nach einem leichtem Rücksetzer notieren die Scheine damit wieder über 100 Euro. Grund für den Aufschlag ist ein positiver... ► Artikel lesen | |
| PROGYNY | 32,040 | -1,42 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
| MOBILE-HEALTH NETWORK SOLUTIONS | 23,890 | +0,46 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
| NEWGENIVF GROUP | 1,780 | +36,92 % | Pre-market Movers: Tevogen Bio, Freight Technologies, NewGenIvf Group, Snap, U.S. Silica | MOUNTAIN VIEW (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 09.15 A.M. ET).In the Green Tevogen Bio Holdings Inc. (TVGN) is up over... ► Artikel lesen | |
| ATRICURE | 23,170 | +2,48 % | AtriCure upgraded at Oppenheimer on valuation | ||
| ADAPTHEALTH | 9,960 | +3,97 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 10,580 | +1,63 % | BrightSpring Health Services appoints Timothy Wick to its board of directors | ||
| LIFEMD | 11,950 | +10,44 % | LifeMD, Inc.: LifeMD to Report First Quarter 2024 Financial Results on May 8 | ||
| ECKERT & ZIEGLER | 36,720 | +1,89 % | Eckert & Ziegler: Gewinnanstieg zum Jahresauftakt | Vorläufigen Zahlen zufolge hat Eckert & Ziegler im ersten Quartal 2024 einen Umsatzanstieg von 57,9 Millionen Euro auf 67,6 Millionen Euro verbucht. Das Berliner Radiopharma-Unternehmen meldet zudem... ► Artikel lesen |
AUTONOMIX MEDICAL INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 3,340 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
